These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Preventive effects of Bifidobacterium- and Lactobacillus-fermented milk on the development of inflammatory bowel disease in senescence-accelerated mouse P1/Yit strain mice. Matsumoto S; Watanabe N; Imaoka A; Okabe Y Digestion; 2001; 64(2):92-9. PubMed ID: 11684822 [TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of gastritis in ileitis-prone SAMP1/Yit mice. Ernst PB; Wiznerowicz EB; Feldman SH; Tung KS Keio J Med; 2011; 60(2):65-8. PubMed ID: 21720202 [TBL] [Abstract][Full Text] [Related]
5. In vivo demonstration of T lymphocyte migration and amelioration of ileitis in intestinal mucosa of SAMP1/Yit mice by the inhibition of MAdCAM-1. Matsuzaki K; Tsuzuki Y; Matsunaga H; Inoue T; Miyazaki J; Hokari R; Okada Y; Kawaguchi A; Nagao S; Itoh K; Matsumoto S; Miura S Clin Exp Immunol; 2005 Apr; 140(1):22-31. PubMed ID: 15762871 [TBL] [Abstract][Full Text] [Related]
6. Omega-3 polyunsaturated fatty acids ameliorate the severity of ileitis in the senescence accelerated mice (SAM)P1/Yit mice model. Matsunaga H; Hokari R; Kurihara C; Okada Y; Takebayashi K; Okudaira K; Watanabe C; Komoto S; Nakamura M; Tsuzuki Y; Kawaguchi A; Nagao S; Miura S Clin Exp Immunol; 2009 Dec; 158(3):325-33. PubMed ID: 19793338 [TBL] [Abstract][Full Text] [Related]
7. Decreased production of interleukin-10 and transforming growth factor-β in Toll-like receptor-activated intestinal B cells in SAMP1/Yit mice. Mishima Y; Ishihara S; Aziz MM; Oka A; Kusunoki R; Otani A; Tada Y; Li YY; Moriyama I; Oshima N; Yuki T; Amano Y; Matsumoto S; Kinoshita Y Immunology; 2010 Dec; 131(4):473-87. PubMed ID: 20561083 [TBL] [Abstract][Full Text] [Related]
8. STAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice. Mitsuyama K; Matsumoto S; Rose-John S; Suzuki A; Hara T; Tomiyasu N; Handa K; Tsuruta O; Funabashi H; Scheller J; Toyonaga A; Sata M Gut; 2006 Sep; 55(9):1263-9. PubMed ID: 16682432 [TBL] [Abstract][Full Text] [Related]
9. Emergence of perianal fistulizing disease in the SAMP1/YitFc mouse, a spontaneous model of chronic ileitis. Rivera-Nieves J; Bamias G; Vidrich A; Marini M; Pizarro TT; McDuffie MJ; Moskaluk CA; Cohn SM; Cominelli F Gastroenterology; 2003 Apr; 124(4):972-82. PubMed ID: 12671894 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-5 participates in the pathogenesis of ileitis in SAMP1/Yit mice. Takedatsu H; Mitsuyama K; Matsumoto S; Handa K; Suzuki A; Takedatsu H; Funabashi H; Okabe Y; Hara T; Toyonaga A; Sata M Eur J Immunol; 2004 Jun; 34(6):1561-9. PubMed ID: 15162425 [TBL] [Abstract][Full Text] [Related]
11. Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease. Kosiewicz MM; Nast CC; Krishnan A; Rivera-Nieves J; Moskaluk CA; Matsumoto S; Kozaiwa K; Cominelli F J Clin Invest; 2001 Mar; 107(6):695-702. PubMed ID: 11254669 [TBL] [Abstract][Full Text] [Related]
13. Novel model of TH2-polarized chronic ileitis: the SAMP1 mouse. McNamee EN; Wermers JD; Masterson JC; Collins CB; Lebsack MD; Fillon S; Robinson ZD; Grenawalt J; Lee JJ; Jedlicka P; Furuta GT; Rivera-Nieves J Inflamm Bowel Dis; 2010 May; 16(5):743-52. PubMed ID: 19856411 [TBL] [Abstract][Full Text] [Related]
14. Inducible Nitric Oxide Regulates Na-Glucose Co-transport in a Spontaneous SAMP1/YitFc Mouse Model of Chronic Ileitis. Palaniappan B; Sundaram S; Arthur S; Afroz S; Sundaram U Nutrients; 2020 Oct; 12(10):. PubMed ID: 33065982 [TBL] [Abstract][Full Text] [Related]
15. Identification of a quantitative trait locus for ileitis in a spontaneous mouse model of Crohn's disease: SAMP1/YitFc. Kozaiwa K; Sugawara K; Smith MF; Carl V; Yamschikov V; Belyea B; McEwen SB; Moskaluk CA; Pizarro TT; Cominelli F; McDuffie M Gastroenterology; 2003 Aug; 125(2):477-90. PubMed ID: 12891551 [TBL] [Abstract][Full Text] [Related]
16. Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease. Odashima M; Bamias G; Rivera-Nieves J; Linden J; Nast CC; Moskaluk CA; Marini M; Sugawara K; Kozaiwa K; Otaka M; Watanabe S; Cominelli F Gastroenterology; 2005 Jul; 129(1):26-33. PubMed ID: 16012931 [TBL] [Abstract][Full Text] [Related]
17. Cilostazol, a specific PDE-3 inhibitor, ameliorates chronic ileitis via suppression of interaction of platelets with monocytes. Matsunaga H; Hokari R; Higashiyama M; Kurihara C; Okada Y; Watanabe C; Komoto S; Nakamura M; Kawaguchi A; Nagao S; Miura S Am J Physiol Gastrointest Liver Physiol; 2009 Dec; 297(6):G1077-84. PubMed ID: 19815627 [TBL] [Abstract][Full Text] [Related]
18. Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli. Heimesaat MM; Fischer A; Jahn HK; Niebergall J; Freudenberg M; Blaut M; Liesenfeld O; Schumann RR; Göbel UB; Bereswill S Gut; 2007 Jul; 56(7):941-8. PubMed ID: 17255219 [TBL] [Abstract][Full Text] [Related]
19. Linkage to peroxisome proliferator-activated receptor-gamma in SAMP1/YitFc mice and in human Crohn's disease. Sugawara K; Olson TS; Moskaluk CA; Stevens BK; Hoang S; Kozaiwa K; Cominelli F; Ley KF; McDuffie M Gastroenterology; 2005 Feb; 128(2):351-60. PubMed ID: 15685547 [TBL] [Abstract][Full Text] [Related]
20. The SAMP1/Yit mouse: another step closer to modeling human inflammatory bowel disease. Strober W; Nakamura K; Kitani A J Clin Invest; 2001 Mar; 107(6):667-70. PubMed ID: 11254665 [No Abstract] [Full Text] [Related] [Next] [New Search]